07-Oct-2010 - China leads the field in 'potential future' API suppliers, positioning it to become a dominant force as these companies develop, Thomson Reuters said at CPhI 2010.
07-Oct-2010 - Cargill is using CPhI 2010 to launch a formulation of its Zerose erythritol excipient for use in orally disintegrating tablets (ODT).
06-Oct-2010 - Univar is now exclusively distributing Dow's Carbowax Sentry PEGs in Europe and the range is proving popular at CPhI 2010 with manufacturers facing restricted supply from other sources.
04-Oct-2010 - Cost-effective, large-scale production of oncology drug Taxol (paclitaxel) intermediates could eventually be achieved using engineered Escherichia coli.
30-Sep-2010 - Zydus Nycomed expects commercial production at its newly commissioned API plant in Navi Mumbai, India to begin in December 2010.
27-Sep-2010 - Prosonix says UMAX particle tech-based LABA/ICS drug developed with partner Chiesi offers compliance, convenience and efficacy advantages.
23-Sep-2010 - GlaxoSmithKline (GSK) has entered into two unrelated development deals by signing license agreements for Delphi Genetics’ StabyExpress for its vaccine production operations and OncoMethylome Sciences’ DNA methylation specific PCR biomarkers for its cancer immunotherapy programme.
23-Sep-2010 - Reengineering erythropoietin (EPO) as an immunoglobulin G (IgG) fusion protein enables penetration of the blood-brain barrier (BBB) in mice, according to researchers.
20-Sep-2010 - SOCMA CEO predicts reintroduction of rejected permanent R&D tax credit plan and urges Congress to act “sooner rather than later” to support US manufacturers.
20-Sep-2010 - Life Technologies has concluded license agreements, providing rights to its proprietary Chinese hamster ovary (CHO) cell lines for production of recombinant proteins used as therapeutic agents and vaccines.
13-Sep-2010 - Scientists say counterfeit drug and ingredient detection using NQR could benefit both manufacturers and pharmacies.
13-Sep-2010 - Japanese excipient maker Hayashibara will access new markets through expanded deal with long-standing partner DKSH.
09-Sep-2010 - Bend Research is bolstering its hot-melt extrusion service capabilities by installing new equipment at its contract manufacturing site.
08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.
07-Sep-2010 - DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, has announced the launch of InnoSyn route scouting services, meeting pharma needs to outsource process development R&D.
06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.
06-Sep-2010 - Aurobindo Pharma is to supply AstraZeneca with solid dosage and sterile generic products for sale in emerging products.
02-Sep-2010 - iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.
01-Sep-2010 - NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.
31-Aug-2010 - Cell culture, LAIV vaccines and recombinant DNA technology should be supported by the US government as part of a long-term overhaul of pandemic response capabilities, according to PCAST.
30-Aug-2010 - Proposed changes to compulsory licensing and foreign ownership oversight in India sparked discussion last week. To explore the topic, in-PharmaTechnologist presents interactive charts detailing market changes in the country over the past 15 years.
30-Aug-2010 - Lonza buys viral-based biologics maker Vivante GMP Solutions to broaden custom manufacturing offering.
30-Aug-2010 - Proposed changes to compulsory licensing and foreign ownership oversight in India sparked discussion last week. To explore the topic, in-PharmaTechnologist presents interactive charts detailing market changes in the country over the past 15 years.
25-Aug-2010 - Indian pharmaceutical firm Cipla is to buy Meditab Specialties to boost active pharmaceutical ingredient (API) and intermediate production capacity.
25-Aug-2010 - A review of US capabilities has concluded that the time to produce a pandemic vaccine could be halved through adoption of short-term policies.